Beta blockers list

AFA Australia Beta Blockers FACT sheet

beta-blockers can cause coldness of the fi ngers and toes. In particularly susceptible people this can cause a transient loss of circulation to the fi ngers and toes making them white and painful, this is called Raynaud’s Phenomenon and is an indication to stop the beta-blocker.

September 15th,2020

Potentially Harmful Drugs in the Elderly: Beers List and More

(Tambocor), sotalol (Betapace), beta-blocker, dofetilide (Tikosyn)27 Beta-blockers in patient with asthma, COPD, or Raynaud’s disease (C)15 Worsening disease15 Alternate antihypertensive; nitrate or calcium channel blocker15 Calcium channel blocker in patient with systolic heart failure (C) or chronic constipation (B, C) Worsening heart failure;

September 15th,2020

Oral Beta Blockers Available in the US

Sep 29, 2016 · Oral Beta Blockers Available in the US Key: UPPER CASE= Brand name Lower case= Generic name * List is cross indexed for Brand and generic names Acebutolol (SECTRAL) Atenolol (TENORMIN) Atenolol/chlorthalidone (TENORETIC) BETAPACE (Sotalol) BETAPACE AF (Sotalol) Betaxolol

September 15th,2020

AFA Australia Beta Blockers FACT sheet

beta-blockers can cause coldness of the fi ngers and toes. In particularly susceptible people this can cause a transient loss of circulation to the fi ngers and toes making them white and painful, this is called Raynaud’s Phenomenon and is an indication to stop the beta-blocker.

September 15th,2020

Application to WHO BB for HF 111210

1) Adding beta-blockers as a therapeutic class for medicines for treatment of patients with heart failure (Section 12.4 of the current List); and 2) Changing the named member of the beta-blocker class from atenolol to a cost-effective agent that can address all indications for beta-blockade (Section 12.1-12.4 of the current

September 15th,2020

Beta-Blockers Therapeutic Class Review (TCR)

beta-blockers are one of the classes suggested in patients with coronary artery disease, post-MI, HF, and diabetes. 43 The role of beta-blockers as initial therapy, particularly in the absence of compelling indications, for hypertension has been questioned.44 Beta-blockers have demonstrated similar efficacy in MI patients

September 15th,2020

CARDIOVASCULAR CONDITIONS: THE THERAPEUTIC USE OF …

TUE Physician Guidelines – Cardiovascular Beta-blockers - Version 2.2 – September 2018 This Guideline is reviewed annually to determine whether revisions to the Prohibited List or new medical practices or standards warrant revisions to the document. If no changes are deemed warranted in the course of this annual review, the existing version

September 15th,2020

Drug Class Review on Beta Adrenergic Blockers

Beta blockers inhibit the chronotropic, inotropic and vasoconstrictor responses to the catecholamines, epinephrine and norepinephrine. Most beta blockers have half-lives of over six hours (Table 1). The shortest acting are pindolol (3-4 hours) and propranolol (3-5 hours). Most beta blockers are metabolized in combination by the liver and kidneys.

September 15th,2020

Evidence-Based Beta Blockers - American Heart Association

The positive findings in the three evidenced based beta blockers are not indicative of a beta blocker class effect and are specific to these three medications. Coding Instructions –Beta Blocker Contraindications 1/28/2014 ©2010, American Heart Association 30.

September 15th,2020

BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

Beta-blockers vary in the degree of elimination by the kidney or the liver, usually with extensive first-pass metabolism. Lipid-soluble beta-blockers, e.g. labetalol, metoprolol, pindolol and propranolol, typically depend upon hepatic metabolism for clearance, whereas water soluble beta-blockers e.g. atenolol are cleared by the kidney. Drugs